The September issue of PME is out now in both its print and digital editions and this month our headline news is that we’ve redesigned the magazine to pack it with even more accessible intelligence for industry executives.
There’s more news – running from top-line developments in market access, sales, research and global health to a newly-expanded Digital Intelligence section.
There’s more exclusive industry comment – this month we hear from UCB’s chief executive Roch Doliveux, EFPIA’s Richard Bergstöm and Publicis’ Sam Welch.
And we have a special focus this month on sales strategies, covering therapeutic area leadership and a report that lays bare pharma’s diminishing returns when it comes to sales rep access.
To add to this PME is now quite literally bigger than ever before, with a new wider format whose pages give our news, comment and analysis even more impact.
So, what do you think of the new look? We’d love to hear your views, so please take a few minutes to answer our short online survey.
And if you don’t currently receive PME on a regular basis you can subscribe to the print or digital edition – or keep up with pharma news on a more regular basis via our PMLiVE Daily or Weekly email newsletters.
In this issue…
News
- FDA approves Merck’s PD1 inhibitor; Boehringer job cuts
- Malaria developments; Genzyme MS drug launches
- BMS hep C drug approved; Novo launches diabetes combo
- Ebola virus hits Africa; pharma fast-tracks vaccines
- Pharma takes ice bucket challenge; biosimilar naming
Darwin’s medicine
A company’s DNA is much more than a figure of speech
Diversity
Should religious or moral beliefs influence a doctor’s decision?
M&A trends
2014 has been shaped by major pharma deals
The price is right
Richard Bergström argues for the value of medicines
Consumer health
Industry deals reflect pharma’s increasing interest in consumer products
Going native
Seven steps to innovating your digital strategy
Online audiences
Pharma can help quench doctors’ thirst for knowledge
Dive in
Therapy area leadership can be commercially invaluable
Connected moments
Capturing a patient experience when it occurs
Turkey
Will this highly efficient pharma market be hindered by its price referencing system?
Reaching HCPs
A network of NHS websites offers a new channel
Investing in the future
Roch Doliveux on UCB’s deal with the European Investment Bank
Pipeline
Opioids are on course to dominate cancer pain market
Innovation
Lab-on-a-chip devices are set for the mainstream
Sales rep access
Reps continue to struggle to see doctors
Digital intelligence
Sanofi brings mobile gaming to diabetes
Diabetes drugs
Join the Tweetchat on September 25
The future
Publicis’ Sam Welch on shifts in pharma marketing
People
Senior moves at Sanofi, Astellas, Bayer and more
Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.
PME is also available to download as an app for iPhone, iPad, Android and Kindle Fire
